{
    "nctId": "NCT02895724",
    "briefTitle": "Hyperbaric Oxygen Therapy to Reduce Lymphedema After Breast Cancer -an Explorative Clinical Trial",
    "officialTitle": "Hyperbaric Oxygen Therapy to Reduce Lymphedema After Breast Cancer -an Explorative Clinical Trial",
    "overallStatus": "UNKNOWN",
    "conditions": "Secondary Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Arm volume",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Participant in \"LYCA - exercise\"\n* Declared cancer free\n* Completed chemotherapy and radiotherapy (maximum 1 year after completed treatment)\n* Lymphedema present when measured at \"Lyca-exercise\" 1 year follow-up: \\>3% increase in inter limb volume change from the baseline measurement, AND a score of 2 points or more on NRS for symptoms (heaviness, tightness, swelling), persisting more than 4 weeks\n* Two or more of the following clinical criteria must be present (i-iii are compared with the unaffected side): i) decreased visibility of subcutaneous veins on the ventral lower arm or dorsal hand, ii) loss of normal contours in the region of the medial side of the elbow/distal end of the upper arm, iii) thicker skin and subcutis on palpation, iv) pitting edema.\n\nExclusion Criteria\n\n* Pregnancy\n* Undrained pneumothorax\n* Unability to equalize pressure in the ears in spite of drain treatment by Ear- Nose- and Throat specialist.\n* Severe heart failure detected during pre-examination for HBOT\n* Intractable Claustrophobia non-responsive of standard pre-medication",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}